L-Theanine attenuates cadmium-induced neurotoxicity through the inhibition of oxidative damage and tau hyperphosphorylation

NeuroToxicology

Volumn 57, Issue , 2016, Pages 95-103

  Ben, Peiling ^a,b   Zhang, Zhengping ^c   Zhu, Yanyan ^a   Xiong, Aiying ^a   Gao, Yanhong ^a   Mu, Jianyun ^d   Yin, Zhimin ^a   Luo, Lan ^c  

^a NANJING NORMAL UNIVERSITY   (China)

^b Chuzhou City Vocation College   (China)

^c NANJING UNIVERSITY   (China)

^d Shidao Community Health Service Center   (China)

Author keywords

Cadmium; L Theanine; Neurotoxicity; Oxidative stress; Tau hyperphosphorylation

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLYCOGEN SYNTHASE KINASE 3BETA; MALONALDEHYDE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TAU PROTEIN; THEANINE; CADMIUM; GLUTAMIC ACID DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL BRAIN INJURY; HEAVY METAL BLOOD LEVEL; HIPPOCAMPUS; LOW DRUG DOSE; MALE; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BRAIN INJURY; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIPID PEROXIDATION; METABOLISM; PHOSPHORYLATION; RANDOMIZATION; TUNEL ASSAY;

ANIMALS; APOPTOSIS; BRAIN INJURIES; CADMIUM; CATALASE; DISEASE MODELS, ANIMAL; GLUTAMATES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IN SITU NICK-END LABELING; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; PHOSPHORYLATION; RANDOM ALLOCATION; SUPEROXIDE DISMUTASE; TAU PROTEINS;

EID: 84988040461     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2016.09.010     Document Type: Article

References (72)

1. Alonso, A.D.C., Grundke-Iqbal, I., Iqbal, K., Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2:7 (1996), 783–787.
2. Amara, S., Abdelmelek, H., Garrel, C., Guiraud, P., Douki, T., Ravanat, J.L., Favier, A., Sakly, M., Ben Rhouma, K., Influence of static magnetic field on cadmium toxicity: study of oxidative stress and DNA damage in rat tissues. J. Trace Elem. Med. Biol. 20:4 (2006), 263–269.
3. Ballatore, C., Lee, V.M.-Y., Trojanowski, J.Q., Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8:9 (2007), 663–672.
4. Barnham, K.J., Bush, A.I., Metals in Alzheimer's and Parkinson's diseases. Curr. Opin. Chem. Biol. 12:2 (2008), 222–228.
5. Bartsch, T., Wulff, P., The hippocampus in aging and disease: from plasticity to vulnerability. Neuroscience 309 (2015), 1–16.
6. Borzelleca, J., Peters, D., Hall, W., A 13-week dietary toxicity and toxicokinetic study with L-theanine in rats. Food Chem. Toxicol. 44:7 (2006), 1158–1166.
7. Bramblett, G.T., Goedert, M., Jakes, R., Merrick, S.E., Trojanowski, J.Q., Lee, V.M., Abnormal tau phosphorylation at Ser 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:6 (1993), 1089–1099.
8. Brunden, K.R., Trojanowski, J.Q., Lee, V.M.-Y., Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov. 8:10 (2009), 783–793.
9. Buée, L., Bussiere, T., Buée-Scherrer, V., Delacourte, A., Hof, P.R., Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33:1 (2000), 95–130.
10. Chen, L., Liu, L., Luo, Y., Huang, S., MAPK and mTOR pathways are involved in cadmium-induced neuronal apoptosis. J. Neurochem. 105:1 (2008), 251–261.
11. Chen, L., Xu, B., Liu, L., Luo, Y., Zhou, H., Chen, W., Shen, T., Han, X., Kontos, C.D., Huang, S., Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death. Free Radic. Biol. Med. 50:5 (2011), 624–632.
12. Chen, S., Gu, C., Xu, C., Zhang, J., Xu, Y., Ren, Q., Guo, M., Huang, S., Chen, L., Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network. J. Neurochem. 128:2 (2014), 256–266.
13. Chen, S., Ren, Q., Zhang, J., Ye, Y., Zhang, Z., Xu, Y., Guo, M., Ji, H., Xu, C., Gu, C., N-acetyl-L-cysteine protects against cadmium-induced neuronal apoptosis by inhibiting ROS-dependent activation of Akt/mTOR pathway in mouse brain. Neuropathol. Appl. Neurobiol. 40:6 (2014), 759–777.
14. Cho, H.S., Kim, S., Lee, S.Y., Park, J.A., Kim, S.J., Chun, H.S., Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology 29:4 (2008), 656–662.
15. Choudhuri, S., Liu, W.L., Berman, N.E., Klaassen, C.D., Cadmium accumulation and metallothionein expression in brain of mice at different stages of development. Toxicol. Lett. 84:3 (1996), 127–133.
16. da Silva, M.H., da Rosa, E.J.F., de Carvalho, N.R., Dobrachinski, F., da Rocha, J.B.T., Mauriz, J.L., González-Gallego, J., Soares, F.A.A., Acute brain damage induced by acetaminophen in mice: effect of diphenyl diselenide on oxidative stress and mitochondrial dysfunction. Neurotox. Res. 21:3 (2012), 334–344.
17. del Pino, J., Zeballos, G., Anadón, M.J., Moyano, P., Díaz, M.J., García, J.M., Frejo, M.T., Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels. Arch. Toxicol., 2015, 1–12.
18. Desai, M.J., Gill, M.S., Hsu, W.H., Armstrong, D.W., Pharmacokinetics of theanine enantiomers in rats. Chirality 17:3 (2005), 154–162.
19. Egashira, N., Ishigami, N., Pu, F., Mishima, K., Iwasaki, K., Orito, K., Oishi, R., Fujiwara, M., Theanine prevents memory impairment induced by repeated cerebral ischemia in rats. Phytother. Res. 22:1 (2008), 65–68.
20. El-Maraghy, S.A., Gad, M.Z., Fahim, A.T., Hamdy, M.A., Effect of cadmium and aluminum intake on the antioxidant status and lipid peroxidation in rat tissues. J. Biochem. Mol. Toxicol. 15:4 (2001), 207–214.
21. Fath, T., Eidenmüller, J., Brandt, R., Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J. Neurosci. 22:22 (2002), 9733–9741.
22. Figueiredo-Pereira, M.E., Yakushin, S., Cohen, G., Disruption of the intracellular sulfhydryl homeostasis by cadmium-induced oxidative stress leads to protein thiolation and ubiquitination in neuronal cells. J. Biol. Chem. 273:21 (1998), 12703–12709.
23. Gil, H.-w., Kang, E.-j., Lee, K.-h., Yang, J.-o., Lee, E.-y., Hong, S.-y., Effect of glutathione on the cadmium chelation of EDTA in a patient with cadmium intoxication. Hum. Exp. Toxicol. 30:1 (2011), 79–83.
24. Godt, J., Scheidig, F., Grosse-Siestrup, C., Esche, V., Brandenburg, P., Reich, A., Groneberg, D.A., The toxicity of cadmium and resulting hazards for human health. J. Occup. Med. Toxicol. 1:22 (2006), 1–6.
25. Gupta, A., Chandra, S., Gestational cadmium exposure and brain development: a biochemical study. Ind. Health 29:2 (1990), 65–71.
26. Gurel, Z., Ozcelik, D., Dursun, S., Apoptotic rate and metallothionein levels in the tissues of cadmium-and copper-exposed rats. Biol. Trace Elem. Res. 116:2 (2007), 203–217.
27. Hanger, D.P., Hughes, K., Woodgett, J.R., Brion, J.-P., Anderton, B.H., Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147:1 (1992), 58–62.
28. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:6686 (1998), 702–705.
29. Ji, Y.-L., Wang, H., Zhang, C., Zhang, Y., Zhao, M., Chen, Y.-H., Xu, D.-X., N-acetylcysteine protects against cadmium-induced germ cell apoptosis by inhibiting endoplasmic reticulum stress in testes. Asian J. Androl., 15(2), 2013, 290.
30. Jiang, L.-F., Yao, T.-M., Zhu, Z.-L., Wang, C., Ji, L.-N., Impacts of Cd (II) on the conformation and self-aggregation of Alzheimer's tau fragment corresponding to the third repeat of microtubule-binding domain. Biochim. Biophys. Acta (BBA)-Proteins Proteom. 1774:11 (2007), 1414–1421.
31. Jiang, W., Gao, M., Sun, S., Bi, A., Xin, Y., Han, X., Wang, L., Yin, Z., Luo, L., Protective effect of L-theanine on carbon tetrachloride-induced acute liver injury in mice. Biochem. Biophys. Res. Commun. 422:2 (2012), 344–350.
32. Kakuda, T., Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol. Res. 64:2 (2011), 162–168.
33. Kim, T.I., Lee, Y.K., Park, S.G., Choi, I.S., Ban, J.O., Park, H.K., Nam, S.-Y., Yun, Y.W., Han, S.B., Oh, K.W., l-Theanine, an amino acid in green tea, attenuates β-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-κB pathways. Free Radic. Biol. Med. 47:11 (2009), 1601–1610.
34. Li, G., Ye, Y., Kang, J., Yao, X., Zhang, Y., Jiang, W., Gao, M., Dai, Y., Xin, Y., Wang, Q., l-Theanine prevents alcoholic liver injury through enhancing the antioxidant capability of hepatocytes. Food Chem. Toxicol. 50:2 (2012), 363–372.
35. Liu, S.J., Zhang, J.Y., Li, H.L., Fang, Z.Y., Wang, Q., Deng, H.M., Gong, C.X., Grundke-Iqbal, I., Iqbal, K., Wang, J.Z., Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain. J. Biol. Chem. 279:48 (2004), 50078–50088.
36. Liu, Z., Li, T., Li, P., Wei, N., Zhao, Z., Liang, H., Ji, X., Chen, W., Xue, M., Wei, J., The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer's disease. Oxid. Med. Cell. Longev., 2015, 2015, 352723.
37. Lopez, E., Arce, C., Oset-Gasque, M., Canadas, S., Gonzalez, M., Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radic. Biol. Med. 40:6 (2006), 940–951.
38. Luna-Muñoz, J., García-Sierra, F., Falcón, V., Menendez, I., Chávez-Macías, L., Mena, R., Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. J. Alzheimer's Dis. 8:1 (2005), 29–41.
39. Méndez-Armenta, M., Villeda-Hernández, J., Barroso-Moguel, R., Nava-Ruí, C., Jiménez-Capdeville, M.E., Rí, C., Brain regional lipid peroxidation and metallothionein levels of developing rats exposed to cadmium and dexamethasone. Toxicol. Lett. 144:2 (2003), 151–157.
40. Morita, T., Sobue, K., Specification of neuronal polarity regulated by local translation of CRMP2 and Tau via the mTOR-p70S6K pathway. J. Biol. Chem. 284:40 (2009), 27734–27745.
41. Mu, W., Zhang, T., Jiang, B., An overview of biological production of L-theanine. Biotechnol. Adv. 33:3 (2015), 335–342.
42. Mulot, S., Hughes, K., Woodgett, J., Anderton, B., Hanger, D., PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3β. FEBS Lett. 349:3 (1994), 359–364.
43. Pérez-Vargas, J., Zarco, N., Vergara, P., Shibayama, M., Segovia, J., Tsutsumi, V., Muriel, P., l-Theanine prevents carbon tetrachloride-induced liver fibrosis via inhibition of nuclear factor κB and down-regulation of transforming growth factor β and connective tissue growth factor. Hum. Exp. Toxicol., 2015 (0960327115578864).
44. Panayi, A., Spyrou, N., Iversen, B., White, M., Part, P., Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J. Neurol. Sci. 195:1 (2002), 1–10.
45. Pei, J.J., Hugon, J., mTOR-dependent signalling in Alzheimer's disease. J. Cell. Mol. Med. 12:6b (2008), 2525–2532.
46. Rana, S., Verma, S., Protective effects of GSH, vitamin E, and selenium on lipid peroxidation in cadmium-fed rats. Biol. Trace Elem. Res. 51:2 (1996), 161–168.
47. Rankin, C.A., Sun, Q., Gamblin, T.C., Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol. Neurodegener., 2, 2007, 12.
48. Rao, J., Letada, P., Haverstick, D.M., Herman, M.M., Savory, J., Modifications to the in situ TUNEL method for detection of apoptosis in paraffin-embedded tissue sections. Ann. Clin. Lab. Sci. 28:3 (1998), 131–137.
49. Regan, P., Piers, T., Yi, J.-H., Kim, D.-H., Huh, S., Park, S.J., Ryu, J.H., Whitcomb, D.J., Cho, K., Tau phosphorylation at serine 396 residue is required for hippocampal LTD. J. Neurosci. 35:12 (2015), 4804–4812.
50. Rickle, A., Bogdanovic, N., Volkmann, I., Zhou, X., Pei, J.-J., Winblad, B., Cowburn, R.F., PTEN levels in Alzheimer's disease medial temporal cortex. Neurochem. Int. 48:2 (2006), 114–123.
51. Singh, T.J., Zaidi, T., Grundke-Iqbal, I., Iqbal, K., Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases. FEBS Lett. 358:1 (1995), 4–8.
52. Siu, E.R., Mruk, D.D., Porto, C.S., Cheng, C.Y., Cadmium-induced testicular injury. Toxicol. Appl. Pharmacol. 238:3 (2009), 240–249.
53. Son, Y.-O., Wang, L., Poyil, P., Budhraja, A., Hitron, J.A., Zhang, Z., Lee, J.-C., Shi, X., Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signaling. Toxicol. Appl. Pharmacol. 264:2 (2012), 153–160.
54. Sugiyama, T., Sadzuka, Y., Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents. Biochim. Biophys. Acta. 1653:2 (2003), 47–59.
55. Sugiyama, T., Sadzuka, Y., Tanaka, K., Sonobe, T., Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin. Toxicol. Lett. 121:2 (2001), 89–96.
56. Sumathi, T., Shobana, C., Thangarajeswari, M., Usha, R., Protective effect of L-Theanine against aluminium induced neurotoxicity in cerebral cortex, hippocampus and cerebellum of rat brain-histopathological, and biochemical approach. Drug Chem. Toxicol. 38:1 (2015), 22–31.
57. Tang, Z., Bereczki, E., Zhang, H., Wang, S., Li, C., Ji, X., Branca, R.M., Lehtiö, J., Guan, Z., Filipcik, P., Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis implication for Alzheimer disease. J. Biol. Chem. 288:22 (2013), 15556–15570.
58. Terashima, T., Takido, J., Yokogoshi, H., Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci. Biotechnol. Biochem. 63:4 (1999), 615–618.
59. Thangarajan, S., Deivasigamani, A., Natarajan, S.S., Krishnan, P., Mohanan, S.K., Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. Int. J. Neurosci. 124:9 (2014), 673–684.
60. Tian, X., Sun, L., Gou, L., Ling, X., Feng, Y., Wang, L., Yin, X., Liu, Y., Protective effect of l-theanine on chronic restraint stress-induced cognitive impairments in mice. Brain Res. 1503 (2013), 24–32.
61. Torra, M., To-Figueras, J., Rodamilans, M., Brunet, M., Corbella, J., Cadmium and zinc relationships in the liver and kidney of humans exposed to environmental cadmium. Sci. Total Environ. 170:1 (1995), 53–57.
62. Vingtdeux, V., Davies, P., Dickson, D.W., Marambaud, P., AMPK is abnormally activated in tangle-and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathol. (Berl.) 121:3 (2011), 337–349.
63. Wang, B., Du, Y., Cadmium and its neurotoxic effects. Oxid. Med. Cell. Longev., 2013, 2013, 898034.
64. Wang, Y., Fang, J., Leonard, S.S., Rao, K.M.K., Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic. Biol. Med. 36:11 (2004), 1434–1443.
65. Wang, J.Z., Grundke-Iqbal, I., Iqbal, K., Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 25:1 (2007), 59–68.
66. Wang, S.-H., Shih, Y.-L., Kuo, T.-C., Ko, W.-C., Shih, C.-M., Cadmium toxicity toward autophagy through ROS-activated GSK-3β in mesangial cells. Toxicol. Sci., 2009, kfn266.
67. Wang, S., Zhou, S.l., Min, F.-y., Ma, J.-j., Shi, X.-j., Bereczki, E., Wu, J., mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice. Metab. Brain Dis. 29:3 (2014), 729–736.
68. Wang, T., Wang, Q., Song, R., Zhang, Y., Yang, J., Wang, Y., Yuan, Y., Bian, J., Liu, X., Gu, J., Zhu, J., Liu, Z., Cadmium induced inhibition of autophagy is associated with microtubule disruption and mitochondrial dysfunction in primary rat cerebral cortical neurons. Neurotoxicol. Teratol. 53 (2016), 11–18.
69. Whittaker, M.H., Wang, G., Chen, X.-Q., Lipsky, M., Smith, D., Gwiazda, R., Fowler, B.A., Exposure to Pb, Cd, and As mixtures potentiates the production of oxidative stress precursors: 30-day, 90-day, and 180-day drinking water studies in rats. Toxicol. Appl. Pharmacol. 254:2 (2011), 154–166.
70. Yang, W.-N., Han, H., Hu, X.-D., Feng, G.-F., Qian, Y.-H., The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress. Pharmacol. Biochem. Behav. 114 (2013), 31–36.
71. Yoshiyama, Y., Lee, V.M., Trojanowski, J.Q., Therapeutic strategies for tau mediated neurodegeneration. J. Neurol. Neurosurg. Psychiatry 84:7 (2013), 784–795.
72. Zhang, D., Gao, J., Zhang, K., Liu, X., Li, J., Effects of chronic cadmium poisoning on Zn, Cu, Fe, Ca, and metallothionein in liver and kidney of rats. Biol. Trace Elem. Res. 149:1 (2012), 57–63.